Richard Ebright, Ph.D.
Richard Ebright, Ph.D., is a Fellow at Nextech Invest Ltd, where he assists in new deal sourcing and evaluation and scientific due diligence. Prior to Nextech, Richard completed a Ph.D. in breast cancer metastasis, with an eye towards small molecule therapeutic opportunities to limit metastatic spread. He also has experience working at an early-stage biotech startup.
Currently, he is an M.D. candidate at Harvard Medical School with hopes to use his medical and research training to develop novel cancer therapeutics. Richard holds a Ph.D. in Biological and Biomedical Sciences from Harvard University and a B.A. in Chemical and Physical Biology from Harvard College.
When not thinking about oncology, Richard enjoys rock climbing and marathon training.